ZACKS INVESTMENT MANAGEMENT - ARRAY BIOPHARMA INC ownership

Back to all holdings Add to watchlist

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 137 filers reported holding ARRAY BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
ZACKS INVESTMENT MANAGEMENT ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q1 2017$165,000
+46.0%
18,505
-51.5%
0.00%0.0%
Q1 2016$113,000
-53.3%
38,181
-25.4%
0.00%
-50.0%
Q4 2014$242,000–51,187–0.01%–
 Download
Other shareholders
ARRAY BIOPHARMA INC shareholders Q1 2016
NameSharesValueWeighting ↓
MUFG Americas Holdings Corp 36,200$71,0000.00%
View complete list of ARRAY BIOPHARMA INC shareholders